Journal article

Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes

Peter J Crack, Moses Zhang, Maria Cristina Morganti-Kossmann, Andrew J Morris, Jonathan M Wojciak, Jonathan K Fleming, Ila Karve, David Wright, Maithili Sashindranath, Yona Goldshmit, Alison Conquest, Maria Daglas, Leigh A Johnston, Robert L Medcalf, Roger A Sabbadini, Alice Pebay

JOURNAL OF NEUROINFLAMMATION | BIOMED CENTRAL LTD | Published : 2014

Grants

Awarded by National Health and Medical Research Council of Australia


Awarded by United States National Institutes of Health


Awarded by NATIONAL CANCER INSTITUTE


Awarded by NATIONAL CENTER FOR RESEARCH RESOURCES


Awarded by NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES


Funding Acknowledgements

The authors thank Mr Duncan Crombie (Centre for Eye Research Australia and University of Melbourne) for his technical assistance. This work was supported by a National Health and Medical Research Council of Australia Project Grant 628391 (PJC), a NHMRC Career Development Award Fellowship (AP), a Transport Accident Commission project grant (AP), the ANZ Trustees Program - Medical Research & Technology in Victoria - William Buckland Foundation (AP), the United States National Institutes of Health (1R43CA132395-01A2 to RM), an Australian Research Council Future Fellowship (PJC), a University of Melbourne Collaboration Grant and the Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program.